baber/WOPTO huggingface dataset:
Patent EP-4096637-A1 (EP)
Inventor: WÖHRMANN YVONNE
IPC: A61P17/00
Filed: 2021-01-26
Abstract: Allergieauslösende Substanzen, Allergene wie Urushiole, werden durch Peptide bestehend aus 2-10 Aminosäuren, wobei mindestens eine Aminosäure ein oder mehreren reaktiven Seitenketten aufweist, abgefangen. Diese Barrierewirkung der Peptide, insbesondere in topisch applizierbaren Zubereitungen, führt zu einer neuartigen antiallergischen Therapieform.
Patent EP-4106746-A1 (EP)
Inventor: JUDKINS ROBERT
IPC: A61P3/06
Filed: 2021-02-11
Abstract: Provided are compounds that can act as a modulator of a farnesoid X receptor (FXR) and that can be useful in the treatment of diseases and/or disorders associated with the FXR. Compositions including such compounds are also provided along with methods for preparing compounds of the present invention and their use.
Patent EP-4233138-A1 (EP)
Inventor: GALLET ANTONIN
IPC: H01S5/50
Filed: 2021-02-22
Abstract: Described is a semiconductor optical amplifier (600, 900) comprising an active layer extending between an input (601, 901) and an output (602, 902) of the optical amplifier, the active layer having a noise suppression part (603, 903) operative to reduce noise of the optical amplifier and a second part (604, 904), the noise suppression part (603, 903) being adjacent to the input (601, 901) of the optical amplifier and having an epitaxial structure different to the second part (604, 904), the noise suppression part (603, 903) being configured to, during operation of the optical amplifier, present a gain that is blue-shifted by at least 20 nm compared to the second part (604, 904). This may allow the noise of the optical amplifier to be reduced, which may improve the performance of the device.
Patent EP-4281812-A1 (EP)
Title: Method and system for processing seismic images to obtain an rgt image by using a decimated seismic dip image
Inventor: KESKES NOOMANE
IPC: G01V1/30
Filed: 2021-01-25
Abstract: The present disclosure relates to a computer implemented method (30) for processing a seismic image comprising at least one horizontal dimension and one vertical dimension, said method comprising: - (S30) determining a seismic dip image based on the seismic image; - (S31 ) decimating the seismic dip image by a decimating factor along at least one horizontal dimension in order to obtain a decimated seismic dip image; - (S32) initializing decimated seismic horizon surfaces; - (S33) iteratively modifying the decimated seismic horizon surfaces to progressively increase alignment between local orientations of each decimated seismic horizon surface and the corresponding local seismic dips of the decimated seismic dip image, said local orientations or local seismic dips being corrected by the decimating factor, until a predetermined stop criterion is satisfied; - (S35) determining a relative geological time, RGT, image based on the decimated seismic horizon surfaces.
Patent EP-4132564-A1 (EP)
Inventor: PINGILI RATNAKAR
IPC: C07K16/28
Filed: 2021-04-09
Abstract: L'invention concerne l'ofatumumab destiné à être utilisé dans le traitement de la sclérose en plaques (SP), le traitement étant un traitement à long terme et le taux d'IgG sérique étant maintenu pendant le traitement. L'invention concerne en outre des inhibiteurs de lymphocytes B et/ou de lymphocytes T destinés à être utilisés dans le traitement de la sclérose en plaques, ledit traitement comprenant la surveillance du taux d'IgG sérique et la sélection d'ofatumumab en tant qu'inhibiteur de lymphocytes B et/ou de lymphocytes T si le taux d'IgG sérique diminue et/ou ledit traitement comprenant l'évaluation de la prédisposition du patient à un risque accru d'infections et la sélection d'ofatumumab en tant qu'inhibiteur de lymphocytes B et/ou de lymphocytes T si une prédisposition est identifiée. L'invention concerne en outre l'ofatumumab destiné à être utilisé dans le traitement de la sclérose en plaques, les patients présentant un taux d'IgG sérique abaissé étant traités et/ou les patients présentant des facteurs de risque associés à des taux d'Ig sérique, en particulier des niveaux d'IgG sériques, étant traités.
Patent EP-4093238-A1 (EP)
Inventor: Rimmer Miriam
IPC: A45D8/36
Filed: 2021-01-20
Abstract: A hair fastener (100) comprises a flexible sheet (102); a plurality of closely spaced hooking elements (106) on a first surface (104) of the sheet (102); and a tab (116) extending from the perimeter of the sheet (102).
Patent EP-4135663-A1 (EP)
Title: Ophthalmic liquid composition comprising low molecular weight linear hyaluronic acid
Inventor: ORESTE PASQUA
IPC: A61K47/02
Filed: 2021-04-16
Abstract: The present invention is related to an ophthalmic liquid composition, useful for example as moisturizer, comprising as the active principle, linear low molecular weight hyaluronic acid (LMWHA).
Patent EP-4146107-A1 (EP)
Title: Control device, electrosurgical instrument and method for controlling an electrosurgical instrument
Inventor: MARTIN LUKAS
IPC: A61B18/00
Filed: 2021-05-07
Abstract: The invention relates to a control device (1) for an electrosurgical instrument (2), in particular a high-frequency sealing instrument, comprising a stationary handle part (3), a movable handle part (4), an activation element (5) for activating a current flow, in particular a first type, preferably a sealing current, wherein the activation element (5) is or can be adjusted between a deactivation position and at least one activation position when the movable handle part (4) is actuated, wherein, when the movable handle part (4) is actuated, the activation element (5) is or can be adjusted about an axis of rotation (7).
Patent EP-4154444-A1 (EP)
Inventor: SARKIS GABI
IPC: H04L1/00
Filed: 2021-04-22
Abstract: A wireless device receives a first set of control information indicating a modulation and coding scheme (MCS) table and receives a second set of control information triggering a channel state information (CSI) report. The wireless device transmits the CSI report including CQI that is based on a channel quality indicator (CQI) table associated with the MCS table indicated in the first set of control information.
Patent EP-4143889-A1 (EP)
Inventor: LICHTENWALNER DANIEL JENNER
IPC: H01L29/417
Filed: 2021-04-27
Abstract: A semiconductor device includes a semiconductor layer structure of a wide band-gap semiconductor material. The semiconductor layer structure includes a drift region having a first conductivity type and a well region having a second conductivity type. A plurality of segmented gate trenches extend in a first direction in the semiconductor layer structure. The segmented gate trenches include respective gate trench segments that are spaced apart from each other in the first direction with intervening regions of the semiconductor layer structure therebetween. Related devices and fabrication methods are also discussed.
Patent EP-4110076-A1 (EP)
Title: Beverage compositions comprising a clouding agent
Inventor: KANG DING
IPC: A23L2/62
Filed: 2021-07-01
Abstract: The present invention relates to a beverage composition comprising a clouding agent selected from the group consisting of coacervate hydrocolloid particles comprising a protein and a polysaccharide, regenerated insoluble dietary fibers, partially soluble dietary fibers, emulsion stabilized by regenerated insoluble dietary fibers and/or partially soluble dietary fibers and any combination thereof, and optionally, one or more beverage ingredients as well as a beverage comprising the same and uses thereof.
Patent EP-4186113-A1 (EP)
Title: Materials for organic electroluminescent devices
Inventor: LINGE ROUVEN
IPC: H01L51/50
Filed: 2021-07-19
Abstract: The present invention relates to a composition comprising a compound of formula (H1) and a compound of formula (H2). The present invention furthermore relates to a formulation comprising a composition comprising a compound of formula (H1) and a formula (H2) and a solvent. Finally, the present invention relates to an electronic device comprising a such a composition.
Patent EP-4179335-A1 (EP)
Title: Method for evaluating the metabolic activity of a non-cancer cell
Inventor: DEL BEN FABIO
IPC: G01N33/84
Filed: 2021-07-02
Abstract: Method for evaluating metabolic activity of non-tumor cells in a biological fluid sample via detection of extra-cellular acidification rate.
Patent EP-4102984-A1 (EP)
Title: Compositions microbiennes et procédés d'utilisation pour l'entéropathie canine et la dysbiose
Inventor: EMBREE MALLORY
IPC: A23K50/48
Filed: 2021-02-10
Abstract: L'invention concerne de nouvelles souches comprenant des micro-organismes isolés de micro-organismes/ensembles microbiens, ainsi que des compositions les comprenant. En outre, l'invention concerne des procédés d'utilisation desdits micro-organismes, des compositions microbiennes et des compositions les comprenant, dans des procédés permettant de moduler la production agricole de ruminants. Dans des aspects particuliers, l'invention concerne des procédés de traitement Ou de prévention de la morbidité et de la mortalité provoquées par la pathogenèse ou l'auto-immunité gastro-intestinale.
Patent EP-4112614-A1 (EP)
Title: Glutarimide skeleton-based compounds and application thereof
Inventor: YANG XIAOBAO
IPC: C07D401/04
Filed: 2021-02-25
Abstract: The present disclosure relates to glutarimide skeleton-based compounds of Formula (I) or a salt, an enantiomer, a stereoisomer, a solvate, or a polymorph thereof, and uses thereof. The present disclosure further relates to a pharmaceutical composition comprising, as an active ingredient, the glutarimide skeleton-based compounds of Formula (I), or a salt, an enantiomer, a stereoisomer, a solvate, or a polymorph thereof, and uses thereof. The series of compounds designed and synthesized in the present disclosure can effectively prevent and/or treat a tumor.
Patent EP-4197200-A1 (EP)
Inventor: KU EMERY M
IPC: H04R25/00
Filed: 2021-08-14
Abstract: A system for detecting feedforward instability in a wearable audio device. The audio device includes an electro-acoustic transducer that is configured to develop sound for a user, a housing that holds the transducer, a feedforward microphone that is configured to detect sound outside of the housing and output a microphone signal, and an opening in the housing that emits sound pressure from the transducer that can reach the microphone. A feedforward instability detector is configured to apply two filters to the microphone signal. A first filter passes more energy in a frequency band than does a second filter, to develop a filtered signal. The filtered signal is compared to the microphone signal outside of the frequency band, to develop a comparison signal that is indicative of feedforward instability in the frequency band.
Patent EP-4208504-A1 (EP)
Inventor: VIETH CHRISTIAN
IPC: C08J11/06
Filed: 2021-09-02
Abstract: La présente invention concerne un procédé de production de filaments à partir de déchets de polyester, comprenant les étapes de broyage mécanique des déchets de polyester, recondensation des déchets de polyester broyés dans la phase solide, et fusion des déchets de polyester recondensés et extrusion de la masse fondue afin de former des filaments. Avant la conduite de l'étape de fusion à des fins d'extrusion, le procédé est intégralement conduit au-dessous de la température de fusion des déchets de polyester. La viscosité de solution des déchets de polyester recondensés est d'au moins 1,7. Des applications possibles des filaments selon l'invention sont des carcasses de renfort pour pneumatiques de véhicules, par exemple.
Patent EP-4211273-A1 (EP)
Inventor: CARTRON PIERRE-FRANÇOIS
IPC: C12Q1/6886
Filed: 2021-09-13
Abstract: La présente invention porte sur la stratification et le traitement de patients souffrant d'un cancer. Comme une thérapie anti-PD1 cible les lymphocytes et l'efficacité d'une thérapie anticancéreuse est mesurée par l'impact sur les cellules tumorales, les inventeurs ont postulé que l'étude des mécanismes moléculaires de la résistance à la thérapie anti-PD1 devrait prendre en compte la communication intercellulaire existante entre les lymphocytes et les cellules tumorales. Comme les exosomes sont des vecteurs du transfert intercellulaire du miARN responsable de la chimiorésistance, ils ont ici cherché à savoir si l'exposition des lymphocytes T à une thérapie anti-PD1 pourrait favoriser l'expression de miARN exosomal (exomiR) provoquant la chimiorésistance des cellules cancéreuses. De manière surprenante, il a été découvert que l'exposition à un agent anti-PD1 des lymphocytes T favorise un enrichissement en miARN-4315 exosomal. Ils ont également noté que le miARN-4315 exosomal induit un phénomène d'apoptorésistance aux chimiothérapies classiques dans les cellules cancéreuses recevant le miARN-4315 exosomal. Au niveau moléculaire, ils discernent que le phénomène d'apoptorésistance est associé à la régulation à la baisse médiée par le miARN-4315 de Bim, une protéine proapoptotique. Dans des modèles cellulaires et de souris, ils ont observé que l'agent mimétique de BH3 ABT263 contourne cette résistance. Ainsi, l'invention porte sur des méthodes de stratification faisant appel au miARN-4315 exosomal et une méthode de traitement de patients souffrant d'un cancer faisant appel à un agent mimétique de BH3.
Patent EP-4129530-A1 (EP)
Inventor: HASHIZUME YOSHIKI
IPC: B33Y10/00
Filed: 2021-03-22
Abstract: An object of the present invention is to provide an additive manufactured object which is free of solidification cracking due to, e.g., heat shrinkage during additive manufacturing of an aluminum alloy; which is free of anisotropy in strength, and has high strength and ductility. An aluminum alloy powder for additive manufacturing includes aluminum alloy particles in which not less than 0.01% by mass and not more than 1% by mass of a grain refiner is trapped. This grain refiner is at least one selected from the borides and carbides of group 4 elements.
Patent EP-4211127-A1 (EP)
Title: Diazinoximes scaffolds
Inventor: BAATI RACHID
IPC: C07D401/06
Filed: 2021-09-10
Abstract: The present invention relates to a compound of formulas (II) to (V). It also relates to a pharmaceutical composition comprising at least one compound of formulas (II) to (V) and at least one pharmaceutically acceptable support. Finally, it relates to the use of such a compound as a medicine, preferably in the treatment of a nervous and/or respiratory failure due to intoxication with at least one organophosphorous nerve agent by reactivation of hAChE; in the treatment of neurological diseases such as Alzheimer's disease; and/or in the treatment of cancer.
Patent EP-4130147-A1 (EP)
Inventor: ARAYAMA KYOHEI
IPC: C09D201/02
Filed: 2021-02-17
Abstract: The composition of the present invention includes specific white particles, a film-forming component, and a solvent, in which the film-forming component includes two or more kinds of resins, or includes one or more kinds of resins and one or more kinds of polymerizable monomers, and at least one of the resin is a resin A which contains a constitutional unit A having a formula weight of 1,000 or more and including a constitutional unit GF with a specific structure and a constitutional unit B having an acidic group, and satisfies at least one of the following requirement 1 or the following requirement 2.Requirement 1: the constitutional unit A includes a molecular chain containing two or more kinds of the constitutional units GF.Requirement 2: the resin A contains two or more kinds of the constitutional units A having different structures of the constitutional unit GF.
Patent EP-4130084-A1 (EP)
Inventor: LIU ZHANZHAN
IPC: C08G18/48
Filed: 2021-02-01
Abstract: Disclosed are a foamed material, a heat-preservation box body, and preparation methods therefor. The foamed material comprises 100 parts of a combined polyol, 10-30 parts of a foaming agent composition, and 120-150 parts of an isocyanate. In the present invention, the type of the polyol used in a foaming system is adjusted in order to increase the content of a polyester polyol and reduce the content of a polyether polyol, such that the compressive strength of the foamed material is significantly improved without increasing or changing the injection amount.foaming material,
Patent EP-4132514-A1 (EP)
Inventor: QI JUN
IPC: A61K31/4155
Filed: 2021-04-05
Abstract: Disclosed are to bifunctional compounds that target PRMT5 for degradation, compositions, and methods for treating diseases or conditions mediated by aberrant arginine methyltransferase 5 (PRMT5) activity.
Patent EP-4132665-A1 (EP)
Title: Systems, methods and apparatus for safe launch and recovery of an inspection vehicle
Inventor: VAGANAY JEROME
IPC: B08B9/093
Filed: 2021-04-02
Abstract: Systems, methods and apparatus for launching and recovering a vehicle via a side manway of a tank are provided. A launcher is coupled to a vertical side of the tank via a manway adapter. The launcher includes a first side having a lid and a second side configured to couple with the manway adapter. The lid is removed from the first side of the launcher. An autonomous vehicle is loaded into the launcher via the first side of the launcher. The lid is placed on the first side of the launcher. The launcher can be pressurized with the autonomous vehicle inside the launcher. The manway adapter is opened at the second side of the launcher to release the flammable fluid into the launcher. Subsequent to opening the manway adapter, the autonomous vehicle launches from the launcher into the tank to perform a tank inspection process.
Patent EP-4087315-A1 (EP)
Inventor: ZHU XIANGYANG
IPC: H04L47/6275
Filed: 2021-01-05
Abstract: Disclosed are a port resource reservation method, an electronic device, and a storage medium. The method provided in the present disclosure comprises: receiving a request message for reserving resources for a service, and determining a resource reservation mode according to the request message (S101); when it is determined that the resource reservation mode is an extension mode, acquiring, according to a pre-set first mapping relationship, an egress port queue corresponding to an extension priority carried in the request message (S103); on the egress port queue corresponding to the extension priority, reserving resources for the service (S 104), wherein the first mapping relationship refers to the correlation between the extension priority and the egress port queue; and acquiring a service identifier from the request message, and establishing a second mapping relationship (S 105), wherein the second mapping relationship refers to the mapping relationship between the service identifier and the extension priority.
Patent EP-3958173-A1 (EP)
Inventor: TIAN FEI
IPC: G06K9/00
Filed: 2021-01-25
Abstract: Provided are a training method and apparatus of a face recognition model, an electronic device and a storage medium, relating to the fields of deep learning, cloud computing and computer vision in artificial intelligence and, in particular, to recognition of a face wearing a mask. The solution includes: using a first block of a face recognition model as a current block and inputting a face image of a current user into the current block; inputting an image feature output by the current block into a current attention module and performing self-weighting processing on the image feature output by the current block; inputting the image feature obtained after the processing into a subsequent block; repeatedly performing the preceding operations until the image feature output by the current block is input into a last block; and training the face recognition model by using an image feature output by the last block. The solution can effectively improve the accuracy with which the face recognition model recognizes a face wearing a mask.
Patent EP-4140405-A1 (EP)
Inventor: YOO DO JOON
IPC: A61B5/097
Filed: 2021-04-08
Abstract: Proposed is a loop-type sampling device and a breathalyzer including the same. The loop-type sampling device includes a body formed in a loop shape forming a central opening through which a gas passes, the body having an entrance into which a part of the gas is introduced, and the body having an inner passage into which a sample gas that is the gas passing through the entrance flows, and includes a sample gas inlet tube having a first end that is in communication with the inner passage, the sample gas inlet tube having a second end connected to a sample gas analysis device that is provided with a negative pressure providing means capable of suctioning the sample gas. The loop-type sampling device and the breathalyzer have an advantage that an infection caused by droplets between a subject and a measurer is capable of being minimized.
Patent EP-4142613-A1 (EP)
Inventor: FEDERSPIEL JOSHUA P
IPC: A61B17/04
Filed: 2021-04-30
Abstract: A button inserter and system are disclosed that enable easily and effectively deploying a near bone suture button from the button inserter when implementing the suture button technique. To deploy the near bone button, with a far bone button deployed from the button inserter and against the far bone, the button inserter's handle may be translated away from the deployed far bone button. Translating the handle changes a position of a carriage body within a channel of the handle thereby compressing a spring. Protrusions on the carriage body may be forced through notches in the handle, which thereby alters an orientation of the carriage and releases the compressed spring, which applies force to the carriage body. The combination of force induces the carriage to rotate, which thereby releases the near bone button from the carriage. A free end of suture also releases from the carriage.
Patent EP-4229791-A1 (EP)
Inventor: NIMBALKER AJIT
IPC: H04L1/18
Filed: 2021-10-14
Abstract: Systems and methods related to Hybrid Automatic Repeat Request (HARQ) timing for Downlink Control Information (DCI) scheduling multiple cells are disclosed. In one embodiment, a method performed by a wireless communication device comprises receiving, from a base station, a DCI that schedules downlink transmissions to the wireless communication 5 device on two or more serving cells. The method further comprises receiving and decoding the downlink transmissions on the two or more serving cells scheduled by the DCI. The method further comprises determining a slot in which to transmit HARQ feedback for the downlink transmissions on the two or more serving cells scheduled by the DCI based on a single HARQ feedback timing indicator comprised in the DCI and a reference timing and transmitting, to the 0 base station, HARQ feedback for the downlink transmissions on the two or more serving cells scheduled by the DCI in the determined slot.
Patent EP-4240783-A1 (EP)
Inventor: VANROY BRAM
IPC: C08G18/10
Filed: 2021-11-04
Abstract: A polyurethane-polyurea comprising water blown foam having an apparent density in the range 30-700 kg/m3 measured according to ISO 845 and having a tensile strength (measured according to DIN 53504) over apparent density ratio of at least 10 kPa.m3/kg. These foams are very suitable for use in footwear and automotive and more in particular in applications aiming for consumer comfort.
Patent EP-4228894-A1 (EP)
Inventor: WALKER LUKE
IPC: B32B18/00
Filed: 2021-10-13
Abstract: Disclosed is a multilayer sintered ceramic body comprising at least one first layer comprising at least one crystalline phase of YAG, wherein the at least one first layer has at least one surface; and at least one second layer comprising alumina and at least one of stabilized zirconia and partially stabilized zirconia, wherein the at least one surface of the at least one first layer comprises pores wherein the pores have a maximum size of from 0.1 to 5 um as measured by SEM, and wherein each of the at least one first layer and the at least one second layer has a coefficient of thermal expansion (CTE), wherein the CTE of the at least one first layer and the CTE of the at least one second layer differ from 0 to 0.6 x 10 -6 /°C as measured in accordance with ASTM E228-17. Methods of making are also disclosed.